Recently, a combination of plasma biomarkers (including proinflammatory high-density lipoprotein, leptin, and TWEAK) and traditional risk factors (age and diabetes) was shown to have a better predictive capacity for the presence of an atherosclerotic plaque than a panel of traditional cardiac risk factors [16]. The gene discussed is LEP; the disease is diabetes mellitus.